Peak6 Investments LLC Alnylam Pharmaceuticals, Inc. Put Options Transaction History

Peak6 Investments LLC

$37.5 Billion
Q2 2024

Put Options

17 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$143.31 - $247.0 $2.01 Million - $3.46 Million	14,000 Added 83.33%	30,800 $7.48 Million
Q1 2024 May 14, 2024	SELL	$146.51 - $198.2 $3.27 Million - $4.42 Million	-22,300 Reduced 57.03%	16,800 $2.51 Million
Q4 2023 Feb 13, 2024	BUY	$151.41 - $196.57 $151,410 - $196,570	1,000 Added 2.62%	39,100 $7.48 Million
Q2 2023 Aug 11, 2023	BUY	$185.01 - $212.05 $1.41 Million - $1.61 Million	7,600 Added 24.92%	38,100 $7.24 Million
Q1 2023 May 12, 2023	SELL	$182.66 - $235.53 $3.25 Million - $4.19 Million	-17,800 Reduced 36.85%	30,500 $6.11 Million
Q4 2022 Feb 10, 2023	BUY	$185.53 - $241.31 $74,212 - $96,524	400 Added 0.84%	48,300 $11.5 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $3.46 Million - $5.8 Million	25,000 Added 109.17%	47,900 $9.59 Million
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $432,412 - $591,294	-3,400 Reduced 12.93%	22,900 $3.74 Million
Q4 2021 Feb 11, 2022	BUY	$159.56 - $209.29 $4.2 Million - $5.5 Million	26,300 New	26,300 $4.46 Million
Q3 2021 Nov 12, 2021	SELL	$169.75 - $207.73 $4.24 Million - $5.19 Million	-25,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$128.63 - $176.89 $9.07 Million - $12.5 Million	-70,500 Reduced 73.82%	25,000 $4.24 Million
Q4 2020 Feb 12, 2021	BUY	$122.97 - $147.0 $24,594 - $29,400	200 Added 0.21%	95,500 $12.4 Million
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $3.75 Million - $5.63 Million	-36,000 Reduced 27.42%	95,300 $14.1 Million
Q1 2020 May 14, 2020	BUY	$93.12 - $133.99 $1.8 Million - $2.59 Million	19,300 Added 17.23%	131,300 $14.3 Million
Q4 2019 Feb 13, 2020	BUY	$74.51 - $124.23 $1.27 Million - $2.12 Million	17,100 Added 18.02%	112,000 $12.9 Million
Q3 2019 Nov 08, 2019	BUY	$70.9 - $87.82 $5.81 Million - $7.19 Million	81,900 Added 630.0%	94,900 $7.63 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $856,180 - $1.21 Million	13,000 New	13,000 $943,000

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

Capital World Investors Los Angeles, CA

15M
Shares

$4.12 Billion
0.61% of portfolio
Vanguard Group Inc Valley Forge, PA

12.5M
Shares

$3.44 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.62 Billion
0.05% of portfolio
Wellington Management Group LLP Boston, MA

6.21M
Shares

$1.71 Billion
0.28% of portfolio
Baillie Gifford & CO

6.03M
Shares

$1.66 Billion
1.16% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Account